To CANCER IMMUNITY Home Page

Table 4

Proportion of vaccinated patients with a preexisting positive assay for peptide-specific CD8+ T-cells.

Assay

Cohort

Proportion of patients a

Flu

Mel

ESO1a

ESO1b

ICS

No imiquimod

8/8

4/7

2/9

2/9

Imiquimod

8/8

3/8

3/8

0/8

Tetramer

No imiquimod

9/9

6/8

ND

3/9

Imiquimod

7/7

6/8

ND

1/7

a Abbreviation: ND, not done.

 

Copyright © 2004 by Jonathan Cebon